Compare Bandhan Healthcare Fund vs UTI Healthcare Fund
Risk | Very High | Very High |
Rating | - | 4.0 |
Min SIP Amount | ₹100 | ₹500 |
Expense Ratio | 2.38 | 2.28 |
NAV | ₹9.72 | ₹270.41 |
Fund Started | 10 Nov 2025 | 01 Aug 2005 |
Fund Size | ₹291.59 Cr | ₹1101.63 Cr |
Exit Load | Exit load of 0.50%, if redeemed within 30 days. | Exit load of 1% if redeemed within 30 days. |
Risk
Very High
Very High
Rating
-
4.0
Min SIP Amount
₹100
₹500
Expense Ratio
2.38
2.28
NAV
₹9.72
₹270.41
Fund Started
10 Nov 2025
01 Aug 2005
Fund Size
₹291.59 Cr
₹1101.63 Cr
Exit Load
Exit load of 0.50%, if redeemed within 30 days.
Exit load of 1% if redeemed within 30 days.
1 Year | - | -3.53% |
3 Year | - | 22.40% |
5 Year | - | 13.59% |
1 Year
-
-3.53%
3 Year
-
22.40%
5 Year
-
13.59%
Equity | 73.81% | 99.40% |
Cash | 25.95% | 0.59% |
Equity
73.81%
99.40%
Cash
25.95%
0.59%
Top 10 Holdings |
|
|
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 10.05% |
Apollo Hospitals Enterprise Ltd. | 7.55% |
Dr. Reddy's Laboratories Ltd. | 6.48% |
Cipla Ltd. | 6.30% |
Max Healthcare Institute Ltd. | 6.18% |
Divi's Laboratories Ltd. | 5.55% |
JB Chemicals & Pharmaceuticals Ltd. | 4.25% |
Ajanta Pharma Ltd. | 2.85% |
Syngene International Ltd. | 2.78% |
Glenmark Pharmaceuticals Ltd. | 2.00% |
Sun Pharmaceutical Industries Ltd. | 9.37% |
Ajanta Pharma Ltd. | 7.16% |
Lupin Ltd. | 5.65% |
Glenmark Pharmaceuticals Ltd. | 4.06% |
Gland Pharma Ltd. | 3.60% |
Procter & Gamble Health Ltd. | 3.46% |
Dr. Reddy's Laboratories Ltd. | 3.46% |
Cipla Ltd. | 3.43% |
Alkem Laboratories Ltd. | 3.40% |
Apollo Hospitals Enterprise Ltd. | 3.39% |
Name | Viraj Kulkarni | - |
Start Date | 10 Nov 2025 | - |
Name
Viraj Kulkarni
-
Start Date
10 Nov 2025
-
Description | The scheme seeks to generate long-term capital appreciation by investing predominantly in equity and equity-related instruments of companies engaged in Healthcare, Pharma and Allied sectors. | The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector. |
Launch Date | 10 Nov 2025 | 01 Aug 2005 |
Description
The scheme seeks to generate long-term capital appreciation by investing predominantly in equity and equity-related instruments of companies engaged in Healthcare, Pharma and Allied sectors.
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector.
Launch Date
10 Nov 2025
01 Aug 2005